Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial

BACKGROUND: Lung cancer patients undergoing palliative chemotherapy exhibit many symptoms related to the disease, such as adverse events and infectious complications during treatment, which impacts directly their health-related quality of life (HRQOL). Nutritional status is a relevant aspect among a...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Almeida Preto, Daniel, Baston, Mariana Toledo, Geraige, Camilla Centurion, Augusto, Sarah Bertazzi, de Oliveira, Marco Antonio, Mamere, Augusto Elias, Pinto, Gustavo Dix Junqueira, Dias, Josiane Mourão, De Marchi, Pedro Rafael Martins, Paiva, Bianca Sakamoto Ribeiro, Paiva, Carlos Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485167/
https://www.ncbi.nlm.nih.gov/pubmed/31023257
http://dx.doi.org/10.1186/s12885-019-5599-z

Ejemplares similares

Ejemplares similares